A Clinical Pathway for the Care of Critically Ill Patients With Asthma in the Community Hospital Setting.

Autor:	Smith A; Boston Children's Hospital, Boston, Massachusetts; and alla.smith@childrens.harvard.edu., Banville D; South Shore Hospital, South Weymouth, Massachusetts., Gruver EJ; Boston Children's Hospital, Boston, Massachusetts; and., Lenox J; South Shore Hospital, South Weymouth, Massachusetts., Melvin P; Boston Children's Hospital, Boston, Massachusetts; and., Waltzman M; Boston Children's Hospital, Boston, Massachusetts; and.
Jazyk:	angličtina
Zdroj:	Hospital pediatrics [Hosp Pediatr] 2019 Mar; Vol. 9 (3), pp. 179-185. Date of Electronic Publication: 2019 Feb 06.
DOI:	10.1542/hpeds.2018-0197
Abstrakt:	Objectives: The management of severe pediatric asthma exacerbations is variable. The use of clinical pathways has been shown to decrease time to clinical recovery and length of stay (LOS) for critically ill patients with asthma in freestanding children's hospitals. We sought to determine if implementing a clinical pathway for pediatric patients who are on continuous albuterol in a community hospital would decrease time to clinical recovery and LOS. Methods: A clinical pathway for guiding the initiation, escalation, and weaning of critical asthma therapies was adapted to a community hospital without a PICU. There were 2 years of baseline data collection (from September 2014 to August 2016) and 16 months of intervention data collection. Segmented regression analysis of interrupted time series was used to evaluate the pathway's impact on LOS and time to clinical recovery. Results: There were 129 patients in the study, including 69 in the baseline group and 60 in the intervention group. After pathway implementation, there was an absolute reduction of 10.2 hours (SD 2.0 hours) in time to clinical recovery ( P ≤ .001). There was no significant effect on LOS. There was a significant reduction in the transfer rate (27.5% of patients in the baseline period versus 11.7% of patients in the intervention period; P = .025). There was no increase in key adverse events, which included the percentage of patients who required ICU-specific therapies while awaiting transfer (7.3% of patients in the baseline period versus 1.7% of patients in the intervention period; P = .215). Conclusions: The implementation of a clinical pathway for the management of critically ill children with asthma and on continuous albuterol in a community hospital was associated with a significant reduction in time to clinical recovery without an increase in key adverse events. Competing Interests: POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose. (Copyright © 2019 by the American Academy of Pediatrics.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu